LPCN Stock, Lipocine Inc. Information
Stock Information
Get LPCN Alerts
News, Short Squeeze, Breakout and More Instantly...
About Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company product TLANDO is an oral testosterone replacement therapy TRT. It also has other products in the pipeline such as LPCN 1144 LPCN 1148 and LPCN 1107.